FOGHORN THERAPEUTICS INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$31M
R&D
$85M
D&A
$3M
Operating Income
$-86M
EBITDA
$-83M
Interest Expense
—
Other Income/Expense
$16M
Pretax Income
$-87M
Tax Provision
$0
Net Income
$-74M
Operating Margin
-279.5%
Net Margin
-240.3%
Effective Tax Rate
0.0%
Deferred Tax Assets
$0
Deferred Tax Liabilities
$234K
DTA Valuation Allowance
$188M
Tax Credit Carryforwards
$13M
NOL Carryforwards
$55M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
Operating Lease Cost
$6M
Revenue YoY Variation
36.8%
Income YoY Variation
15.9%